Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression

A legfontosabb adatok

Ki végzi
University of North Carolina, Chapel Hill
Hol
Chapel Hill (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
10 fő vett részt
Kezdés
2022. aug. 5.
Befejezés
2023. nov. 15.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Brexanolone
A regiszteradat frissítve
2025. január 28.

Ki vehet részt

Életkor
18 év – 45 év
Nem
Csak nők
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 29 feltétel megnézéseKevesebb

Ki vehet részt

  • Signed informed consent
  • Documented proof of full COVID-19 vaccination
  • Ambulatory, female, aged 18-45
  • ≤ 8 months postpartum
  • Agrees to adhere to the study requirements
  • Onset of depression in 3rd trimester or within 4 weeks of delivery
  • Meets DSM-V criteria for major depressive disorder with peripartum onset
  • 17-item HAM-D total score ≥20 at screening
  • Stopped breastfeeding or agrees to temporarily stop for 7 days including 4 days of hospitalization and 3 days after
  • No new psychotropic drugs during screening and active treatment of study
  • Stable use of any current psychotropic drugs for at least 28 days prior to enrollment, with stable dosage for at least 14 days prior to enrollment
  • Must be on documented contraceptive
  • Must have a caregiver or family member with them to help care for the subject's child(ren) during the infusion and to be in the room with the subject if the child(ren) are present during the infusion

Ki nem vehet részt

  • Concurrent substance abuse
  • Exposure to another investigational medication or device within 30 days
  • Has previously participated in any study employing brexanolone or SAGE-217
  • Has received electroconvulsive therapy during current episode
  • Renal impairment or failure, hepatic impairment or failure, or anemia
  • Known allergy to progesterone or allopregnanolone
  • Medical history of schizophrenia, and/or schizoaffective disorder
  • Current psychotic symptoms including delusions, hallucinations, or formal thought disorder
  • History of seizure disorder
  • Positive pregnancy test at screening or day 1
  • Pregnancy that resulted in a stillbirth, termination, or child that was placed for adoption
  • Untreated or inadequately treated hypothyroidism or hyperthyroidism
  • Suicide attempt at this episode
  • Subject is investigative site personnel, sponsor personnel, or an immediate member of their family
  • On anticonvulsant agents
  • On benzodiazepines

Helyszínek itt: Egyesült Államok

  • University of North CarolinaChapel Hill, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is a feasibility study of performing repeated EEG recordings and assessment of affective states during open-label administration of BRX to women with postpartum depression. Study phases will include screening, enrollment, intervention, and follow-up. Subjects will be screened for study eligibility criteria through clinical assessments and self-report. Enrolled subjects will be admitted to the UNC Women's Hospital, where five serial EEG recordings will be obtained, along with frequent assessments of affective state, before, during, and after a 60-hour IV infusion of BRX. Follow-up procedures will include assessments of PPD and affective symptoms, as well as an exit interview with the study team. If feasibility outcomes are achieved, exploratory EEG analyses will be performed with AMICA (adaptive mixture independent component analysis), community detection, and microstate assessment. Exploratory analyses of data collected by facial expression detection software (iMotions Affectiva) are also planned.

A vizsgált kezelések

  • Brexanolone

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression: a Feasibility Study
Publikációk
A regiszteradat frissítve
2025. január 28.